Minnesota Inadvertently Allows Unregulated Intoxicating Cannabis Edible Products July 6, 2022 Ian Stewart Minnesota 0 Comments By Ian A. Stewart As of July 1, 2022, unregulated intoxicating THC products derived from hemp have been legalized in Minnesota, apparently as the result of confusion by state legislators about the new law’s actual effect. Although the express intent… Read More→
Michigan’s New Cannabis Liability Insurance Requirements Raise Concerns by Licensees, Insurers January 11, 2022 Ian Stewart Insurance, Michigan 0 Comments Authors: Ian A. Stewart and William S. Cook Michigan has adopted new legislation that unintentionally may make Michigan cannabis companies and their insurers scramble to determine how to comply with onerous regulations around mandatory product liability insurance. Without materially consulting… Read More→
Delta-9 THC Products from Hemp Are a Risk Not Worth Taking November 29, 2021 Ian Stewart Hemp Policy & Legal, Insurance 0 Comments The hemp-derived cannabinoid market continues to grow and evolve despite lingering questions over federal legality and numerous state laws that try to keep pace. Much has been written about new “legal” hemp products that contain intoxicating delta-8 THC, delta-10 THC… Read More→
U.S. Senate’s Cannabis Administration and Opportunity Act Clarifies How Federal Government May Regulate Marijuana but Leaves Unanswered Questions July 21, 2021 Ian Stewart Federal 3 Comments The much-anticipated proposed Senate bill that would legalize marijuana on the federal level was made public on July 14, 2021, by its lead sponsor, Senate Majority Leader Charles Schumer (D-New York). Called the Cannabis Administration and Opportunity Act, it removes… Read More→
Cannabis Directors and Officers Liability: Cause for Optimism? June 30, 2021 Ian Stewart Insurance 0 Comments Cannabis companies are confronted by the twin challenge of warding off an increasing number of expensive lawsuits brought against their directors and officers armed with inadequate available insurance policies to respond to those suits. Securities litigation, shareholder and investor disputes,… Read More→
Justice Thomas Criticizes Federal Marijuana Policy and Questions Whether Prohibition Remains Necessary or Proper June 29, 2021 Ian Stewart Federal 0 Comments By: Ian A. Stewart US Supreme Court Justice Clarence Thomas has issued an unexpected statement questioning whether the federal government’s continuing prohibition on marijuana is necessary or proper. His statement was made accompanying the denial of a writ of certiorariin… Read More→
The SAFE Banking and CLAIM Acts Will Transform the Cannabis Insurance Industry – Here’s What to Expect March 24, 2021 Ian Stewart Federal, Insurance 0 Comments Like the opening bell on the trading floor of the Stock Exchange, the reintroduction in Congress last week of the long-awaited Secure and Fair Enforcement (SAFE) Banking Act and related Clarifying Law Around Insurance of Marijuana (CLAIM) Act was a… Read More→
Cannabis and Appellate Law Practices Collaborate to Prepare Amicus Brief to U.S. Supreme Court in Challenge to Marijuana’s Schedule I Status September 23, 2020 Ian Stewart Policy & Legal 0 Comments by: Melissa A. Murphy-Petros, Ian A. Stewart, Neil M. Willner The National Cannabis Industry Association (NCIA), the largest cannabis trade association in the United States, and The Arcview Group (Arcview), the cannabis industry's oldest and largest investor network, stepped forth as… Read More→
Cannabis and the Federal Courts August 12, 2020 Ian Stewart Federal 0 Comments By Ian A. Stewart All participants within the cannabis industry should understand the potential risks of litigating disputes in the federal courts. Federal policy regarding enforcement of the Controlled Substances Act (CSA) has shown ambivalence where the possession and distribution of… Read More→
Cannabis and CBD Companies Subject to Increased Prop 65 Exposure June 22, 2020 Ian Stewart California 0 Comments By Ian A. Stewart Cannabis and CBD companies must prepare for increased liability under California’s notorious Proposition 65 statute. THC has been added to the list of chemicals for which Prop 65 warnings are required. The statute now identifies THC… Read More→
Hemp-Derived THC Products: Legal or Loophole? May 26, 2020 Ian Stewart Hemp Policy & Legal 0 Comments By Ian A. Stewart, Devon Mills and Neil Willner Hemp-derived CBD products have exploded onto the market since Congress removed hemp from the Controlled Substances Act (CSA) in the 2018 Farm Bill. Now, new hemp-derived products are emerging that contain… Read More→
THCP: Newly Discovered Form of THC Could Help Explain Potency Variations in Cannabis Strains and May Lead to New Product Label Requirements January 22, 2020 Ian Stewart Compliance and Regulations, Packaging, Science and Technology 0 Comments The pharmacological effects of most cannabinoids remain a mystery. Despite more than 120 identified cannabinoids in the cannabis plant, very few other than THC (tetrahydrocannabinol) and CBD (cannabidiol) have been isolated and characterized in terms of their pharmacological properties. The… Read More→
Three New Developments: The Vaping Crisis, Stakes Are Raised For The Cannabis Industry October 5, 2019 Ian Stewart News & Insights, Vaping Crisis 0 Comments In the last week, and specifically the last twenty four hours, several new stories have emerged that raise the stakes for The Cannabis Industry by the Vaping Crisis. One story begs the question of whether the industry has the ability to… Read More→
The First of the Vape-Lung Product Liability Cases Has Been Filed September 30, 2019 Ian Stewart Policy & Legal, Spotlight, Vaping Crisis 0 Comments A product liability lawsuit has been filed in Washington state court against several manufacturers of THC vape cartridges. The case, Charles Wilcoxson v. Canna Brand Solutions LLC et al.,was filed on September 23, 2019, in the Superior Court of Pierce… Read More→
CBD Labeling and Marketing: The Straight Story September 16, 2019 Ian Stewart Hemp Policy & Legal 0 Comments By Ian A. Stewart and Neil Willner Cannabidiol (CBD) products are being marketed, advertised and labeled in a manner that is giving rise to substantial regulatory exposure and civil tort liability. Setting aside the FDA’s current prohibition on CBD in… Read More→